These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9217621)

  • 41. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators.
    Simons LA
    Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.
    Tobert JA
    Circulation; 1987 Sep; 76(3):534-8. PubMed ID: 3113763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the effectiveness of lipid-lowering therapy (bile acid sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia in veterans.
    Schectman G; Hiatt J; Hartz A
    Am J Cardiol; 1993 Apr; 71(10):759-65. PubMed ID: 8456750
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P; Colombo F; Cattaneo R; Geroli L; Venco A
    Int J Clin Pharmacol Res; 1992; 12(2):65-70. PubMed ID: 1428300
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central nervous system effects of HMG CoA reductase inhibitors: lovastatin and pravastatin on sleep and cognitive performance in patients with hypercholesterolemia.
    Kostis JB; Rosen RC; Wilson AC
    J Clin Pharmacol; 1994 Oct; 34(10):989-96. PubMed ID: 7836550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of lovastatin in the treatment of primary hypercholesterolemia].
    Chi JM; Li LS; Sun MZ
    Zhonghua Nei Ke Za Zhi; 1992 Jan; 31(1):32-4, 61. PubMed ID: 1395911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study.
    Probstfield JL; Margitic SE; Byington RP; Espeland MA; Furberg CD
    Am J Cardiol; 1995 Sep; 76(9):47C-53C. PubMed ID: 7572686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of folate supplementation on serum homocysteine and plasma total antioxidant capacity in hypercholesterolemic adults under lovastatin treatment: a double-blind randomized controlled clinical trial.
    Shidfar F; Homayounfar R; Fereshtehnejad SM; Kalani A
    Arch Med Res; 2009 Jul; 40(5):380-6. PubMed ID: 19766902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonate.
    Beil FU; Schrameyer-Wernecke A; Beisiegel U; Greten H; Karkas JD; Liou R; Alberts AW; Eckardt HG; Till AE
    Cardiology; 1990; 77 Suppl 4():22-32. PubMed ID: 2073669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. Effect of patient characteristics on lovastatin-induced changes in plasma concentrations of lipids and lipoproteins.
    Shear CL; Franklin FA; Stinnett S; Hurley DP; Bradford RH; Chremos AN; Nash DT; Langendorfer A
    Circulation; 1992 Apr; 85(4):1293-303. PubMed ID: 1555273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cholesterol lowering in the elderly. Results of the Cholesterol Reduction in Seniors Program (CRISP) pilot study.
    LaRosa JC; Applegate W; Crouse JR; Hunninghake DB; Grimm R; Knopp R; Eckfeldt JH; Davis CE; Gordon DJ
    Arch Intern Med; 1994 Mar; 154(5):529-39. PubMed ID: 8122946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia. A multicenter study. The Lovastatin Study Group II.
    JAMA; 1986 Nov; 256(20):2829-34. PubMed ID: 3534333
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.
    Evans M; Rumberger JA; Azumano I; Napolitano JJ; Citrolo D; Kamiya T
    Vasc Health Risk Manag; 2014; 10():89-100. PubMed ID: 24600231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 6-month trial of simvastatin (HMG-CoA reductase inhibitor) in the treatment of hypercholesterolaemia.
    Steyn K; Weich HF; Vermaak WJ; Marais AD; Omar MA; Van Gelder AL; Fourie J; Kotze TJ; Stander I; Firth JC
    S Afr Med J; 1991 Jun; 79(11):639-45. PubMed ID: 2047945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.
    Ose L; Davidson MH; Stein EA; Kastelein JJ; Scott RS; Hunninghake DB; Campodonico S; Insull W; Escobar ID; Schrott HG; Stepanavage ME; Wu M; Tate AC; Melino MR; Mercuri M; Mitchel YB
    Clin Cardiol; 2000 Jan; 23(1):39-46. PubMed ID: 10680028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial.
    Stein EA; Illingworth DR; Kwiterovich PO; Liacouras CA; Siimes MA; Jacobson MS; Brewster TG; Hopkins P; Davidson M; Graham K; Arensman F; Knopp RH; DuJovne C; Williams CL; Isaacsohn JL; Jacobsen CA; Laskarzewski PM; Ames S; Gormley GJ
    JAMA; 1999 Jan; 281(2):137-44. PubMed ID: 9917116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors.
    Mortensen SA; Leth A; Agner E; Rohde M
    Mol Aspects Med; 1997; 18 Suppl():S137-44. PubMed ID: 9266515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
    Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
    Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multicenter double-blind study comparing lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia.
    Vallés F; Anguita M; Anglada J; Aguirre C; Fabiani F; Plaza L; Soriguer F; Azanza JR; Barcina C
    Atherosclerosis; 1991 Dec; 91 Suppl():S3-9. PubMed ID: 1789815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.